PSCR (Proto Script Pharmaceutical) Buyback Yield %: 0.00 (As of Aug. 04, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Proto Script Pharmaceutical Buyback Yield %?

Proto Script Pharmaceutical PSCR Buyback Yield % is 0.00 as of Aug. 04, 2026.

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

Proto Script Pharmaceutical's current buyback yield was 0.00%.

Proto Script Pharmaceutical Buyback Yield % Related Terms

Proto Script Pharmaceutical Buyback Yield % Historical Data

* Premium members only.

The historical data trend for Proto Script Pharmaceutical's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Proto Script Pharmaceutical Buyback Yield % Chart

Proto Script Pharmaceutical Annual Data
Trend May12 May13 May14 May15 May16
Buyback Yield %
-0.26 -0.84 0.00 0.00 0.00

Proto Script Pharmaceutical Quarterly Data
Nov12 Feb13 May13 Aug13 Nov13 Feb14 May14 Aug14 Nov14 Feb15 May15 Aug15 Nov15 Feb16 May16 Sep16 Dec16 Mar17 Jun17 Sep17
Buyback Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

PSCR vs EXCC, NXES, PRZM: Buyback Yield % Comparison

For the Specialty Business Services subindustry, Proto Script Pharmaceutical's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Proto Script Pharmaceutical Buyback Yield % vs Business Services Industry

For the Business Services industry and Industrials sector, Proto Script Pharmaceutical's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where Proto Script Pharmaceutical's Buyback Yield % falls into.


Proto Script Pharmaceutical Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

Proto Script Pharmaceutical's Buyback Yield for the fiscal year that ended in May. 2016 is calculated as

Buyback Yield=Net Issuance of Stock / Market Cap
=- (Repurchase of Stock + Issuance of Stock) / Market Cap
=- (0 + 0) / 0.64008
=0.00%

Proto Script Pharmaceutical's annualized Buyback Yield for the quarter that ended in Sep. 2017 is calculated as

Buyback Yield=Net Issuance of Stock(TTM) / Market Cap
=- (Repurchase of Stock + Issuance of Stock) (TTM)** / Market Cap
=- (0 + 0) / 1.86732
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** If the quarter corresponds to the year-end period, we will use the annual Repurchase of Stock and Issuance of Stock data .

Frequently Asked Questions Learn more about Buyback Yield % →
What does a Buyback Yield % of 0.00 mean?
Proto Script Pharmaceutical (PSCR) has a Buyback Yield % of 0.00 as of Aug. 04, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Proto Script Pharmaceutical and its competitors.
Is Proto Script Pharmaceutical's Buyback Yield % too high?
Proto Script Pharmaceutical's current Buyback Yield % is 0.00.
How does Proto Script Pharmaceutical's Buyback Yield % compare to EXCC and NXES?
Proto Script Pharmaceutical's Buyback Yield % of 0.00 can be compared against companies in the Business Services industry. The industry median Buyback Yield % is 0.07. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Business Services company?
The median Buyback Yield % among Business Services companies is 0.07, based on 427 companies in the industry. Companies in the top quartile (top 25%) have a Buyback Yield % significantly above this median, while those in the bottom quartile fall well below. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Proto Script Pharmaceutical and its competitors. For the Business Services industry, the median Buyback Yield % is 0.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Proto Script Pharmaceutical's current Buyback Yield % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Proto Script Pharmaceutical stock overvalued right now?
Proto Script Pharmaceutical (PSCR) has a current Buyback Yield % of 0.00. The current Buyback Yield % is 0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For Proto Script Pharmaceutical (PSCR), the current Buyback Yield % is 0.00 as of Aug. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Proto Script Pharmaceutical Business Description

Address 9830 6th Street, Suite 103, Rancho Cucamonga, CA, USA, 91730
Proto Script Pharmaceutical Corp is primarily in the business of repair power wheelchairs and scooters, which are classified as durable medical equipment (DME) products and reimbursable by healthcare insurance providers. It has various contracts with state and governmental insurance providers, among others. These contracts provide the company with the right to sell and repair DME and its health care insurance contracts allow it the ability to service patients nationally. The group currently has its presence of repair facilities in Las Vegas, Nevada, Rancho-Cucamonga, and Anaheim, California.